<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Just How Corrupted Has American Medicine Become&#63;</title>
	<atom:link href="http://chelseagreen.com/blogs/brucelevine/2009/01/14/just-how-corrupted-has-american-medicine-become/feed/" rel="self" type="application/rss+xml" />
	<link>http://chelseagreen.com/blogs/brucelevine/2009/01/14/just-how-corrupted-has-american-medicine-become/</link>
	<description>Just another The Chelsea Green Weblogs weblog</description>
	<pubDate>Wed, 22 May 2013 13:43:07 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
		<item>
		<title>By: A. C. Paul</title>
		<link>http://chelseagreen.com/blogs/brucelevine/2009/01/14/just-how-corrupted-has-american-medicine-become/#comment-2</link>
		<dc:creator>A. C. Paul</dc:creator>
		<pubDate>Wed, 14 Jan 2009 20:08:32 +0000</pubDate>
		<guid isPermaLink="false">http://chelseagreen.com/blogs/brucelevine/?p=3#comment-2</guid>
		<description>The original problem behind off-label usage is that the FDA would require the same redundancy in testing, paperwork, trials, etc, that the drug went through for its first approval. If the drug is already a generic, the millions of dollars the approval costs is not at all cost-effective. 

So yes, gabapentin is used off-label for the treatment of diabetic neuropathy. The drug is EFFECTIVE and SAFE, and is a non-narcotic way of relieving some types of nerve pain. Given that, does it matter how its marketed to the docs?

As a nurse, evidenced-based practice is the gold standard. Therefore, when I admit a diabetic patient with neuropathies, I will ask the admitting doc is gabapentin is called for. And the makers of Neurontin never wooed me. Or my coworkers. We just want what's best for the patient.</description>
		<content:encoded><![CDATA[<p>The original problem behind off-label usage is that the FDA would require the same redundancy in testing, paperwork, trials, etc, that the drug went through for its first approval. If the drug is already a generic, the millions of dollars the approval costs is not at all cost-effective. </p>
<p>So yes, gabapentin is used off-label for the treatment of diabetic neuropathy. The drug is EFFECTIVE and SAFE, and is a non-narcotic way of relieving some types of nerve pain. Given that, does it matter how its marketed to the docs?</p>
<p>As a nurse, evidenced-based practice is the gold standard. Therefore, when I admit a diabetic patient with neuropathies, I will ask the admitting doc is gabapentin is called for. And the makers of Neurontin never wooed me. Or my coworkers. We just want what&#039;s best for the patient.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
